Dundee Corp Cl A (DDEJF) 5.8253 $DDEJF Dundee

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Dundee Corp Cl A (DDEJF) 5.8253 $DDEJF

Dundee Corporation Announces Voting Results for Election of Directors
Marketwired - Tue Jun 07, 3:43PM CDT
TORONTO, ONTARIO--(Marketwired - Jun 7, 2016) - In accordance with regulatory requirements, Dundee Corporation (TSXC.A) ("Dundee" announces that at the annual meeting of shareholders (the "Meeting" held on June 6, 2016, all of the nominees for election as directors of Dundee referred to in its Management Proxy Circular for the Meeting were elected by way of show of hands. If a ballot vote had been taken, based solely on proxies received by Dundee, the voting results for the election of directors would have been as follows:
DC-A.TO: 7.59 (+0.18)

Dundee Corporation Acquires Further Interest in Formation Metals Inc.
Marketwire Canada - Fri Jun 03, 4:23PM CDT
TORONTO, ONTARIO--(Marketwired - Jun 3, 2016) - In accordance with regulatory requirements, Dundee Corporation (TSXC.A) announces that, through its wholly owned subsidiary, Dundee Resources Limited, it has acquired 833,400 units ("Units" of Formation Metals Inc. (the "Issuer" at the price of $0.30 per Unit for aggregate consideration of $250,020. Each Unit is comprised of one common share in the capital of the Issuer and one-half of one share purchase warrant (each whole warrant, a "Warrant". Each Warrant entitles the holder to acquire, on payment of $0.40, one common share in the capital of the Issuer at any time during a 24-month period.
DC-A.TO: 7.59 (+0.18)

Dundee Corporation Reports First Quarter 2016 Financial Results
Marketwired - Mon May 16, 6:02AM CDT
TORONTO, ONTARIO--(Marketwired - May 16, 2016) - Dundee Corporation (TSXC.A) (the "Corporation" or "Dundee" is reporting its financial results for the three months ended March 31, 2016. The net loss for the first quarter of 2016 attributable to shareholders was $6.1 million or a loss of $0.13 per share, compared with a net loss of $27.0 million or $0.50 per share incurred during the first quarter of the prior year.
DC-A.TO: 7.59 (+0.18)

Dundee Corporation Declares Quarterly First Preference Shares, Series 5 Dividend
Marketwired - Fri May 13, 12:19PM CDT
TORONTO, ONTARIO--(Marketwired - May 13, 2016) - Dundee Corporation (TSXC.A)(TSXC.PR.E) ("Dundee" announced today that its board of directors has approved the payment of a quarterly cash dividend of $0.46875 per cumulative first preference share, series 5 payable on June 30, 2016 to shareholders of record on June 16, 2016.
DC-A.TO: 7.59 (+0.18), DC-PR-E.TO: 23.79 (-0.11)

Dundee Sustainable Technologies Appoints Vice-President of Business Development
Marketwired - Wed May 11, 9:57AM CDT
MONTREAL, QUEBEC--(Marketwired - May 11, 2016) - Dundee Sustainable Technologies Inc. ("DST" or the "Corporation" (CSEST) is pleased to announce the appointment of Mr. Jean-Philippe Mai as Vice-President of Business Development. Mr. Mai holds a Bachelor of Science in Geology from the University of Quebec in Montreal ("UQAM" and has a vast experience in mining projects in Canada, Australia and South America. Mr. Mai has been the Senior Geologist of DST since January 2013 and has been a key player in the development of the Corporation's ongoing and future projects. Mr. Mai, is a Professional Geologist and a member, in good standing, of l'Ordre des Géologues du Québec ("OGQ" and may act as a "Qualified Person" as defined by Regulation 43-101.

Dundee Corporation Announces Notice of Redemption in Respect of Its Series 5 Preferred Shares
Marketwired - Tue May 10, 7:04AM CDT
TORONTO, ONTARIO--(Marketwired - May 10, 2016) - Dundee Corporation (TSXC.A)(TSXC.PR.E) (the "Company" today announced that it has issued a Notice of Redemption in respect of the redemption of up to a maximum of 15% of the issued and outstanding Series 5 Preferred Shares, at a price of $25.00 per Series 5 Preferred Share, plus any accrued and unpaid dividends (the "Redemption Price", on June 30, 2016 (the "Redemption Date" pursuant to the share provisions of the Series 5 Preferred Shares. The redemption is at the election of the beneficial holders of the Series 5 Preferred Shares, who have the right (the "Redemption Deposit Right" to deposit and have redeemed up to a maximum of 15% of the Series 5 Preferred Shares beneficially owned by them at the Redemption Price on the Redemption Date.
DC-A.TO: 7.59 (+0.18), DC-PR-E.TO: 23.79 (-0.11)

Dundee Corporation Acquires Further Interest in Xylitol Canada Inc.
Marketwired - Tue Apr 12, 4:01PM CDT
In accordance with regulatory requirements, Dundee Corporation (TSX: DC.A) ("Dundee" announces that it has acquired, through a wholly owned subsidiary, a $250,000 secured convertible debenture, as part of a secured financing and a $250,000 unsecured convertible debenture, as part of an unsecured financing (together the "Debentures" of Xylitol Canada Inc. ("Xylitol". The Debentures are convertible into common shares of Xylitol at a price of $0.10 per share. As part of the secured financing, Dundee received 2,500,000 warrants, each warrant being exercisable into one common share of Xylitol at $0.08 for a period of two years. As part of the unsecured financing, Dundee received 500,000 warrants, each warrant being exercisable into one common share of Xylitol at $0.15 for a period of 18 months.
DC-A.TO: 7.59 (+0.18)

Dundee Corporation Reports 2015 Fourth Quarter and Full Year Financial Results
Marketwired - Wed Mar 30, 6:14PM CDT
Dundee Corporation (TSX: DC.A) (the "Corporation" or "Dundee" is reporting its financial results for the three months and full year ended December 31, 2015. The net loss for the fourth quarter of 2015 attributable to shareholders was $55 million or a loss of $0.97 per share, compared with a net loss of $178 million or $3.20 per share incurred during the same period of the prior year. On a year-to-date basis, the net loss attributable to shareholders was $459 million or $7.99 per share, compared with a net loss of $318 million or $5.93 per share for the prior year.
DC-A.TO: 7.59 (+0.18)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 2

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 1

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 1

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 5

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 1

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 7

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 8

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 3

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 2

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 10

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading

Top 5 Most Recently Viewed Articles

Acumen Pharmaceuticals to Showcase Innovations at Conference

Updated Category News Views 115

Acumen Pharmaceuticals to Present at Health Conference Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a pioneering clinical-stage biopharmaceutical company, is set to engage in a significant fireside chat at the 7th Annual Evercore ISI HealthCONx Conference. This event will happen shortly, providing a platform for Acumen to discuss their innovative approaches to tackling...

Continue Reading
Chanson International Holding Reports Fiscal Year 2025 Mid-Year Results

Updated Category News Views 192

Chanson International Holding Reports Mid-Year Financial Results Chanson International Holding (NASDAQ: CHSN) has recently unveiled its financial performance for the first half of the fiscal year 2025. As a key player in the bakery and beverage sectors, the company's unaudited results signify its resilience in a fluctuating market. Overview of Financial Performance...

Continue Reading
Investors Are Strategically Analyzing REGN Options Activity

Updated Category News Views 66

Examining Recent Changes in REGN Options There's been a noteworthy shift in sentiment among financial experts regarding Regeneron Pharmaceuticals. A recent analysis of the trading patterns in REGN options has revealed a blend of bullish and bearish movements in the market. This information serves as a foundation for understanding the current factors that are shaping...

Continue Reading
Analysts Raise Price Targets for CVS After Strong Earning Report

Updated Category News Views 99

CVS Health Exceeds Expectations with Recent Earnings CVS Health Corp (NYSE: CVS) delivered an impressive earnings report for its fourth quarter, showing robust sales numbers that surpassed analysts' expectations. The company announced fourth-quarter sales totaling an incredible $97.71 billion, outpacing the consensus estimate of $97.19 billion. Adjusted Earnings Report...

Continue Reading
Healthcare Triangle and Teyame AI Join Forces to Innovate Patient Engagement

Updated Category News Views 161

Healthcare Triangle Announces Strategic Partnership with Teyame AI Healthcare Triangle, Inc. (Nasdaq: HCTI) is excited to share its recent agreement with Teyame AI LLC, a visionary corporation aiming to revolutionize customer experience through artificial intelligence. This partnership is a transformative step that will not only enhance HCTI's SaaS capabilities but is...

Continue Reading